Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition


View by channel
 

View all webcasts/CME by date

Immunology

      mm/dd/yyyy
12/15/2009The Use of B-Cell-Directed Therapies in SLE, Vasculitis, and Other Autoimmune Diseases
12/14/2009Emerging Safety Issues in Biologics 2009: Progressive Multifocal Leukoencephalopathy
10/19/2009Role of Biologic Therapy for the Autoinflammatory Syndromes
10/01/2009Biologic Therapies III The New Agents
09/30/2009Autoimmune and Inflammatory Disorders from Bench to Bedside
08/13/2009Advances in Hereditary Angioedema Treatment: Considerations, Criteria & the New Therapy Options for Treatment & Prevention of HAE Attacks
08/11/2009Update in Hereditary Angioedema: A Disease in Rapid Evolution
07/03/2009Safety of Novel Immunomodulatory Therapies
06/29/2009Biologics in Crohn's Disease: Treating Early, Treating Long-Term
06/29/2009Long-Term Sustainability Using Biologics in Crohn's Disease
06/29/2009Recent Updates in Crohn's Disease: Optimising Remission, Healing, and Quality of Life
04/17/2009Managing Postherpetic Neuralgia: Identifying Risk Factors, Assessing Impact, and Reducing Pain
04/06/2009Immunocompetence and Biologic Therapies: Assessing Risks and Preventing Complications from Infections - Panel Discussion
04/03/2009Infectious Complications of Biologic Therapies: Preventive and Therapeutic Strategies
03/31/2009Relative Risks of Serious Bacterial and Opportunistic Infections Among Biologics: Results of Randomized Trials and Observational Studies
03/30/2009Importance of Assessing Immunocompetence in Biologic Drug Development
02/12/2009Using Biologics to Improve Both Physical and Social Function in Rheumatic Diseases
02/12/2009Rheumatic Diseases: Using Anti-TNF-alpha Agents to Improve Everyday Patient Function
02/12/2009Treating to Target: Long-Term Safety and Efficacy in Rheumatoid Arthritis
11/13/2008B-Cell Biology and B-Cell-Targeted Therapies for Autoimmune Rheumatic Diseases: The Role of the Allied Health Professional
11/13/2008Achieving Clinical Response and Improving Quality of Life With TNF-Alpha Antagonists in Patients With Psoriasis
11/13/2008A Practical Approach to Optimising Psoriasis Treatment With Anti-TNF-Alpha Monoclonal Antibodies
11/13/2008Achieving Long-Term Efficacy and Safety in Psoriasis Treatment With Anti-TNF-Alpha Agents
11/12/2008Advances in B-Cell Biology in the Treatment of Autoimmune and Inflammatory Diseases
09/02/2008Heparin-Induced Thrombocytopenia: Diagnosis and Treatment
08/25/2008Clinical Implications of New Data on Iron Overload in Patients With MDS
08/25/2008Practical Implications of New Canadian Guidelines on Treating Iron Overload in MDS
08/25/2008Effective and Safe Iron Chelation Therapy for Iron Overloaded Patients With Myelodysplastic Syndromes
08/25/2008Considerations for Optimal Patient Management of Iron Overload
08/08/2008Adjuvant Interferon Therapy Prolongs Relapse-Free Interval and Survival in Melanoma



         More webcasts/CME>>>




All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.